(Q78435470)

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2624

14 December 2019

title

Ganoderic acid D, E, F, and H and lucidenic acid D, E, and F, new triterpenoids from Ganoderma lucidum. (English)

1 reference

14 December 2019

1 reference

1 reference

methyl (2R,6R)-2-methyl-4-oxo-6-[(5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoate

1 reference

methyl (2R,6R)-2-methyl-4-oxo-6-[(3S,5R,7S,10S,13R,14R,15S,17S)-3,7,15-trihydroxy-4,4,10,13,14-pentamethyl-11-oxo-1,2,3,5,6,7,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]heptanoate

1 reference

(2R,6R)-6-[(3S,5S,10S,12S,13R,14S,17R)-12-acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

Methyl 4-(12-acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl)pentanoate

1 reference

1 reference

(2S,6R)-6-[(5R,10S,12S,13R,14R,17R)-12-acetyloxy-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

(2r,6s)-6-[(3s,5r,10s,12s,13r,14r,17r)-12-Acetoxy-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxo-heptanoic acid

1 reference

methyl (2R,6R)-6-[(5R,10S,12S,13R,14R,17R)-12-acetyloxy-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoate

1 reference

(2R,6R)-2-methyl-4-oxo-6-[(3S,5R,7S,10R,12S,13S,14R,17S)-3,7,12-trihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid

1 reference

(2S,6R)-6-[(3S,5R,7S,10R,13S,14R,17S)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-4-oxoheptanoic acid

1 reference

(4R)-4-[(1R,3aR,5aR,9aS,11aR)-3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-1H,2H,5H,5aH,8H,9H,11H-cyclopenta[a]phenanthren-1-yl]pentanoic acid

1 reference

1 reference

1 reference

1 reference

methyl (2R,6R)-6-[(3S,5R,10S,12S,13R,14R,17R)-12-acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoate

1 reference

6-[(5R,10S,13R,14R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

Methyl 6-(3,15-dihydroxy-4,4,10,13,14-pentamethyl-11-oxo-1,2,3,5,6,7,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoate

1 reference

methyl 6-(15-hydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoate

1 reference

methyl 2-methyl-4-oxo-6-(3,7,12-trihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoate

1 reference

4-(12-acetyloxy-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl)-4-hydroxypentanoic acid

1 reference

3,15-Dihydroxy-11,23-dioxolanost-8-en-26-oic acid

1 reference

2-methyl-4-oxo-6-[(3S,7S,14R,15S)-3,7,15-trihydroxy-4,4,10,13,14-pentamethyl-11-oxo-1,2,3,5,6,7,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]heptanoic acid

1 reference

1 reference

4-(3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl)-4-hydroxypentanoic acid

1 reference

Tohru Kikuchi

1

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2624

14 December 2019

Satoko Matsuda

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2624

2

1 reference

14 December 2019

Shigetoshi Kadota

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2624

3

1 reference

14 December 2019

Yoshihiro Murai

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2624

4

1 reference

14 December 2019

Zenichi Ogita

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2624

5

1 reference

14 December 2019

language of work or name

English

1 reference

Chemical & Pharmaceutical Bulletin

publication date

1985

3 references

16 September 2022

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/cpb1958/33/6/33_6_2624/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.33.2624?email=unpaywall_01@example.com

published in

Chemical & Pharmaceutical Bulletin

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2624

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2624

14 December 2019

volume

33

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2624

14 December 2019

issue

6

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2624

14 December 2019

page(s)

2624-2627

1 reference

14 December 2019

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.33.2624?email=unpaywall_01@example.com

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

Identifiers

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.2624